Clinical Trial Update: Phase 1 and 2 Study of PX-866 and Cetuximab [Phase 1, Phase 2]

View source ↗

Summary

This document reports a completed Phase 1/2 clinical trial evaluating PX-866 in combination with cetuximab. The study enrolled patients with metastatic colorect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• PX-866 (PX-866)

Snippet

Sponsor: Cascadian Therapeutics Inc. | Conditions: Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | Phase 1, Phase 2 | Status: COMPLETED